Lung Cancer
Volume 69, Issue 1 , Pages 86-93, July 2010

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

  • Nicolas Girard

      Affiliations

    • Department of Radiotherapy-Oncology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, Lyon, France
    • French-speaking Intergroup of Thoracic Oncology (IFCT), Paris, France
    • ,
  • Françoise Mornex

      Affiliations

    • Department of Radiotherapy-Oncology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, Lyon, France
    • French-speaking Intergroup of Thoracic Oncology (IFCT), Paris, France
    • ,
  • Jean-Yves Douillard

      Affiliations

    • French-speaking Intergroup of Thoracic Oncology (IFCT), Paris, France
    • Department of Medical Oncology, Centre René Gauducheau, Saint-Herblain, France
    • ,
  • Nadine Bossard

      Affiliations

    • Department of Epidemiology and Biostatistics, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, Lyon, France
    • ,
  • Elisabeth Quoix

      Affiliations

    • French-speaking Intergroup of Thoracic Oncology (IFCT), Paris, France
    • Department of Respiratory Medicine, Centre Hospitalier Universitaire de Strasbourg, France
    • ,
  • Véronique Beckendorf

      Affiliations

    • French-speaking Intergroup of Thoracic Oncology (IFCT), Paris, France
    • Centre Alexis Vautrin, Vandoeuvre-les-Nancy, Paris, France
    • ,
  • Dominique Grunenwald

      Affiliations

    • French-speaking Intergroup of Thoracic Oncology (IFCT), Paris, France
    • Department of Thoracic Surgery, Hôpital Tenon, Paris, France
    • ,
  • Elodie Amour

      Affiliations

    • French-speaking Intergroup of Thoracic Oncology (IFCT), Paris, France
    • ,
  • Bernard Milleron

      Affiliations

    • French-speaking Intergroup of Thoracic Oncology (IFCT), Paris, France
    • Department of Respiratory Medicine and Thoracic Oncology, Hôpital Tenon, Paris, France
    • Corresponding Author InformationCorresponding author at: Service de Pneumologie, Assistance Publique - Hôpitaux de Paris, Hôpital Tenon, 4, rue de la Chine, 75020 Paris, France. Tel.: +33 1 56 01 62 04; fax: +33 1 56 01 70 02.

Received 28 July 2009; received in revised form 24 September 2009; accepted 1 October 2009. published online 30 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(09)00502-9

doi:10.1016/j.lungcan.2009.10.003

Lung Cancer
Volume 69, Issue 1 , Pages 86-93, July 2010

Article Tools

* Image Usage & Resolution